Novartis Korea executives charged for bribing doctors

Prosecutors have indicted the former chief executive of the South Korean unit of Novartis and five other former and current managers over allegations they illegally paid doctors 2.6 billion won ($2.3 million) in return for prescribing the company's drugs.

The Swiss pharmaceutical company in a statement expressed regret, but also said without elaborating that such conduct would not have been sanctioned by the "most senior management" at Novartis Korea.

Seoul prosecutors say they also indicted 28 others, including and publishers of medical journals, over their suspected involvement in transactions that took place between 2011 and January this year. None of the suspects has been arrested.

Novartis Korea didn't immediately return requests for comment.

Explore further

Novartis could face S.Korea sales ban amid corruption allegations: media

© 2016 The Associated Press. All rights reserved.

Citation: Novartis Korea executives charged for bribing doctors (2016, August 13) retrieved 2 March 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments